RIGEL PHARMACEUTICALS INC (RIGL) Total liabilities 2016–2025
RIGEL PHARMACEUTICALS INC (RIGL) total liabilities at each fiscal year-end, per SEC filings.
$122.1MFY2025 · since FY2016: $23.1M → $122.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $122.1M | -24.0% |
| FY2024 | $160.7M | +10.2% |
| FY2023 | $145.9M | -1.4% |
| FY2022 | $147.9M | +8.0% |
| FY2021 | $137.0M | +79.4% |
| FY2020 | $76.4M | -18.6% |
| FY2019 | $93.8M | +220.7% |
| FY2018 | $29.2M | +58.3% |
| FY2017 | $18.5M | -20.1% |
| FY2016 | $23.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice